Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
RIGEL PHARMACEUTICALS INC (RIGL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 8-K Quarterly results
05/02/2023 8-K Quarterly results
Docs: "Rigel Reports First Quarter 2023 Financial Results and Provides Business Update"
03/07/2023 8-K Quarterly results
Docs: "Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
02/03/2023 8-K Quarterly results
01/09/2023 8-K Quarterly results
12/02/2022 8-K Quarterly results
11/29/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
11/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Rigel Announces Top-line Results from FOCUS Phase 3 Clinical Trial of Fostamatinib in High Risk Hospitalized COVID-19 Patients"
10/11/2022 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Rigel Provides Update on Plans for sNDA for wAIHA Program Following FDA Feedback --Announces Workforce Reduction--"
08/02/2022 8-K Quarterly results
Docs: "Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update"
07/25/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
Docs: "Rigel Reports First Quarter 2022 Financial Results and Provides Business Update"
03/01/2022 8-K Quarterly results
02/17/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
01/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2022 CASH INCENTIVE PLAN Purpose: The terms of the 2022 Cash Incentive Plan have been established to reward the executives and other employees of Rigel Pharmaceuticals, Inc. for assisting the Company in achieving its operational goals through exemplary performance. Under the 2022 Plan, cash bonuses, if any, will be based on the achievement of corporate goals and a review of personal performance, which is determined at the discretion of the Compensation Committee of the Board of Directors and/or the Board of Directors . The overarching intent in setting and achieving the goals is to build long-term shareholder value. Determination of 2022 Cash Bonuses:"
01/10/2022 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "About ITP"
12/17/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/15/2021 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
11/02/2021 8-K Quarterly results
Docs: "Rigel Reports Third Quarter 2021 Financial Results and Provides Business Update"
08/13/2021 8-K Quarterly results
08/03/2021 8-K Quarterly results
Docs: "Rigel Reports Second Quarter 2021 Financial Results and Provides Business Update"
05/21/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
04/13/2021 8-K Quarterly results
03/02/2021 8-K Quarterly results
02/18/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Rigel Reports Third Quarter 2020 Financial Results and Provides Business Update"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy